Injectable antineoplastic, microtubule inhibitor, indicated for the treatment of patients with advanced progressive breast cancer or liposarcoma.
Surprex
Antineoplastic, tyrosine kinase inhibitor. Indicated as an oral treatment for patients with advanced renal cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
Zalutex
Hormonal antineoplastic indicated for oral treatment of prostate cancer patients.
Novex
Antineoplastic. Anti CD20 monoclonal antibody indicated to treat oncohematologic neoplasms such as Non Hodgkin Lymfom, chronic Lymphocytic Leukemia. Rheumatoid arthritis treatment.
Vaxira
Monoclonal antibody indicated in treatment of patients with advanced non small cell lung cancer (NSCLC).
Terfun
Oral antineoplastic, antimetabolite, indicated in treatment to patients with metastatic colorectal cancer refractory to previous treatment with other available therapies.
Cimaher
Antineoplastic. Monoclonal antibody that joins the epidermic growth factor receptor. Indicated in head and neck cancer, esophagus cancer, pancreatic cancer, glioblastoma.
Bevax
Antineoplastic. Anti VEGF monoclonal antibody. Indicated to treat patients with advanced or metastatic tumors such as: colorectal cancer, lung cancer, glioblastoma, ovary cancer, renal cancer, cervix cancer.
